ArticleJournal of imaging2025
Fundus Image-Based Eye Disease Detection Using EfficientNetB3 Architecture.
Article in Journal of imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Scalable Unimodal and Multimodal Deep Learning for Multi-Label Chest Disease Detection: A Comparative Analysis.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate and early classification of retinal diseases such as diabetic retinopathy, cataract, and glaucoma is essential for preventing vision loss and improving clinical outcomes. Manual diagnosis from fundus images is often time-consuming and error-prone, motivating the development of automated solutions. This study proposes a deep learning-based classification model using a pretrained EfficientNetB3 architecture, fine-tuned on a publicly available Kaggle retinal image dataset. The model categorizes images into four classes: cataract, diabetic retinopathy, glaucoma, and healthy. Key enhancements include transfer learning, data augmentation, and optimization via the Adam optimizer with a cosine annealing scheduler. The proposed model achieved a classification accuracy of 95.12%, with a precision of 95.21%, recall of 94.88%, F1-score of 95.00%, Dice Score of 94.91%, Jaccard Index of 91.2%, and an MCC of 0.925. These results demonstrate the model's robustness and potential to support automated retinal disease diagnosis in clinical settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.